SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-046444
Filing Date
2023-12-29
Accepted
2023-12-28 20:50:34
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1307328
2 ex31-1.htm EX-31.1 17916
3 ex32-1.htm EX-32.1 7675
  Complete submission text file 0001493152-23-046444.txt   5526013

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE endv-20230930.xsd EX-101.SCH 40581
5 XBRL CALCULATION FILE endv-20230930_cal.xml EX-101.CAL 41724
6 XBRL DEFINITION FILE endv-20230930_def.xml EX-101.DEF 201462
7 XBRL LABEL FILE endv-20230930_lab.xml EX-101.LAB 351682
8 XBRL PRESENTATION FILE endv-20230930_pre.xml EX-101.PRE 272145
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 776877
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55453 | Film No.: 231524114
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)